(Reuters) – Activist-investor Carl Icahn said his firm had sued current and former board directors at Illumina concerning the acquisition of gene-sequencing company Grail, the Financial Times reported on Tuesday.
(Reporting by Mrinmay Dey in Bengaluru; Editing by Sherry Jacob-Phillips)
